AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitapaz M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Akesiss Pharma Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitapaz M 50mg/500mg Tablet

Diabetics with type 2 mellitus may find relief from elevated blood glucose levels with the dual-action formulation of Metformin/Glimepiride 50mg/500mg tablets. This medication helps mitigate severe diabetic complications, including renal impairment and vision loss, while potentially decreasing the risk of cardiovascular events like strokes and heart attacks. This treatment might be administered independently or in conjunction with other anti-diabetic therapies, achieving optimal results when coupled with a balanced diet and regular physical activity. Dosage is personalized, influenced by individual health status, glucose levels, and existing medications. Ingesting it with meals minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes efficacy; discontinuation should only occur under physician guidance. Adherence to the prescribed dietary and exercise plan is crucial for optimal diabetes management, as lifestyle significantly impacts blood sugar control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia, a potential side effect particularly when used with insulin or sulfonylureas, requires awareness and appropriate management strategies. This medication isn't universally suitable; individuals with pre-existing liver, kidney, or heart conditions, pancreatic issues, or significant alcohol consumption should inform their physician prior to commencing treatment. Pregnant or lactating women should also seek medical counsel. To ensure safe usage, disclose all current medications to your doctor, as interactions are possible. Alcohol consumption should be minimized due to its potential to reduce blood glucose levels. Your physician will monitor your kidney function and blood sugar throughout treatment.

Uses of Sitapaz M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitapaz M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the 50mg/500mg Sitapaz M Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Sitapaz M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitapaz M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Sitapaz M 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sitapaz M 50mg/500mg Tablet works:

Sitapaz M, a 50mg/500mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitapaz M 50mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitapaz M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and the use of Sitapaz M 50mg/500mg tablets are likely incompatible. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitapaz M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Sitapaz M 50mg/500mg tablet use. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Use of Sitapaz M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitapaz M 50mg/500mg Tablet :

Should you forget to take your Sitapaz M 50mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitapaz M 50mg/500mg Tablet

LabelValue
Addictive None.
Type of Medication Medication for diabetes

FAQs on Sitapaz M 50mg/500mg Tablet

Sitagliptin and Metformin, combined as Sitapaz M 50mg/500mg tablets, treat type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a suitable diet and physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin works by suppressing DPP4, thereby boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged Sitapaz M 50mg/500mg Tablet use can indeed lead to vitamin B12 deficiency. This medication hinders the stomach's absorption of vitamin B12. Consequently, untreated deficiency may result in anemia and neurological complications, manifesting as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, according to some studies, include annual supplemental vitamin B12 intake.
Sitapaz M 50mg/500mg Tablet may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Individuals with hypersensitivity to any Sitapaz M 50mg/500mg Tablet constituent should not use this medication. Its use is contraindicated in patients experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitapaz M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Retain this medication in its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Sitapaz M 50mg/500mg Tablet. Also termed Metformin-associated lactic acidosis (MALA), this rare complication necessitates caution, particularly for individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Symptoms such as muscle aches, weakness, vertigo, fatigue, peripheral coldness, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia warrant immediate cessation of Sitagliptin + Metformin and prompt medical attention.
Sitapaz M 50mg/500mg tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication enhances blood sugar control when combined with a healthy diet and regular physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin blocks DPP4, boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Sitapaz M 50mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Individuals with hypersensitivity to any Sitapaz M 50mg/500mg Tablet constituent should not use this medication. Its administration is contraindicated in patients experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitapaz M 50mg/500mg tablets with alcohol is unsafe due to a heightened risk of lactic acidosis.
Lactic acidosis, a serious medical condition resulting from excessive blood lactic acid, is a potential side effect of Sitapaz M 50mg/500mg Tablet. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Its occurrence is heightened in individuals with impaired kidney function, the elderly, and those consuming substantial alcohol. Warning signs may encompass muscular discomfort or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Sitapaz M 50mg/500mg Tablet use and seek immediate medical attention.
Prolonged Sitapaz M 50mg/500mg Tablet use can indeed lead to vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may manifest as anemia and neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and impaired coordination. To mitigate these risks, supplemental vitamin B12 is recommended by some studies at least annually.
Retain this medication within its original, sealed container or packaging. Store as directed on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Sitapaz M 50mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when combined with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin, by inhibiting DPP-4, boosts insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Sitapaz M 50mg/500mg Tablet may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged treatment can result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitapaz M 50mg/500mg Tablet ingredient or inactive substance should not take this medication. Its use is contraindicated in individuals with severely compromised kidney or liver function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitapaz M 50mg/500mg Tablet and alcohol is unsafe due to a heightened risk of lactic acidosis.
Indeed, Sitapaz M 50mg/500mg Tablets may result in lactic acidosis, a serious medical condition characterized by excessive lactic acid in the bloodstream. Also termed MALA (Metformin-associated lactic acidosis), this uncommon adverse reaction associated with metformin is contraindicated in individuals with pre-existing kidney impairment, the elderly, or those who consume significant quantities of alcohol. Presenting symptoms can encompass muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms develop, discontinue Sitagliptin + Metformin immediately and seek urgent medical attention.
Indeed, prolonged Sitapaz M 50mg/500mg Tablet administration can lead to Vitamin B12 insufficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia and neurological complications, manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive alterations, and gait instability. Prophylactic supplemental Vitamin B12, at least annually, is recommended by some experts to mitigate these risks.
Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Sitapaz M 50mg/500mg Tabl...
103
MRP 119
13% off